📰 Controlled Trial Evaluating News
Controlled Trial Evaluating News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Controlled Trial Evaluating. Real-time updates on events, politics, business and more.
November 2, 2023
The second round of late-breaking clinical trials were presented with results from three studies during the Vascular InterVentional Advances Conference, VIVA23, being held Oct. 30-Nov. 2 in Las Vegas, NV. Notably, results from Abbott’s LIFE-BTK randomized clinical trial (RCT) demonstrated that Esprit BTK (Abbott) reduces disease progression and helps improve medical outcomes compared to balloon angioplasty, the current state of care.
October 31, 2023
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
August 30, 2023
/PRNewswire/ -- Leading physicians and researchers will present results from 20 clinical trials from Monday, October 30, to Wednesday, November 1, at the...
April 7, 2023
Natural remedies can do wonders in treating painful mouth ulcers, stomach inflammation, wounds, and infections. When it comes ...
February 28, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
February 28, 2022
PORTSMOUTH, N.H., Feb. 28, 2022 /PRNewswire/ -- Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. ...
February 28, 2022
/PRNewswire/ -- Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), announced that the Therapeutic...